CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 14th Annual BIO CEO & Investor Conference on Tuesday, February 14, 2012 at 3:30 p.m. ET and at the Leerink Swann 2012 Global Healthcare Conference on Wednesday, February 15, 2012 at 3:30 p.m. ET, both being held at the Waldorf=Astoria in New York City.
